BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 17387295)

  • 1. The diagnosis, staging, and treatment options for mycosis fungoides.
    Keehn CA; Belongie IP; Shistik G; Fenske NA; Glass LF
    Cancer Control; 2007 Apr; 14(2):102-11. PubMed ID: 17387295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous T-cell Lymphoma.
    Glass LF; Keller KL; Messina JL; Dalton J; Yag-Howard C; Fenske NA
    Cancer Control; 1998 Jan; 5(1):11-18. PubMed ID: 10761012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycosis fungoides in pediatric patients: Clinical features, diagnostic challenges, and advances in therapeutic management.
    Wu JH; Cohen BA; Sweren RJ
    Pediatr Dermatol; 2020 Jan; 37(1):18-28. PubMed ID: 31630432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical staining for CD45R isoforms in paraffin sections to diagnose mycosis fungoides-type cutaneous T-cell lymphoma.
    Ismail SA; Han R; Sanborn SL; Stevens SR; Cooper KD; Wood GS; Gilliam AC
    J Am Acad Dermatol; 2007 Apr; 56(4):635-42. PubMed ID: 17367612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of mycosis fungoides. Part 1. Diagnosis, staging, and prognosis.
    Smith BD; Wilson LD
    Oncology (Williston Park); 2003 Sep; 17(9):1281-8. PubMed ID: 14569854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
    Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
    Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perplexing Rash: Challenges to Diagnosis and Management of Mycosis Fungoides.
    Aun JA; Patel HS; Patel KK; Cashman J; Bailey E
    J Am Osteopath Assoc; 2018 Jul; 118(7):472-478. PubMed ID: 29946665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and prognostic factors of 114 patients with mycosis fungoides in a Moroccan cohort: a 29-year review.
    Titou H; Bouhamidi A
    Clin Exp Med; 2023 Nov; 23(7):3751-3758. PubMed ID: 37029872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines for phototherapy of mycosis fungoides and Sézary syndrome: A consensus statement of the United States Cutaneous Lymphoma Consortium.
    Olsen EA; Hodak E; Anderson T; Carter JB; Henderson M; Cooper K; Lim HW
    J Am Acad Dermatol; 2016 Jan; 74(1):27-58. PubMed ID: 26547257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The head and neck manifestations of mycosis fungoides.
    Brennan JA
    Laryngoscope; 1995 May; 105(5 Pt 1):478-80. PubMed ID: 7760661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of cutaneous T-cell lymphoma/mycosis fungoides.
    Parker SR; Bradley B
    Dermatol Nurs; 2006 Dec; 18(6):566-70, 573-5. PubMed ID: 17286158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidisciplinary Management of Mycosis Fungoides/Sézary Syndrome.
    Berg S; Villasenor-Park J; Haun P; Kim EJ
    Curr Hematol Malig Rep; 2017 Jun; 12(3):234-243. PubMed ID: 28540671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycosis fungoides: classic disease and variant presentations.
    Howard MS; Smoller BR
    Semin Cutan Med Surg; 2000 Jun; 19(2):91-9. PubMed ID: 10892710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical roundtable monograph. The management of aggressive T-cell lymphoma: a discussion on transformed mycosis fungoides.
    Horwitz SM; Duvic M; Hsi ED
    Clin Adv Hematol Oncol; 2010 Dec; 8(12):1-15. PubMed ID: 21344783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycosis fungoides in pediatric population: comprehensive review on epidemiology, clinical presentation, and management.
    Kothari R; Szepietowski JC; Bagot M; Sandhu S; Patil A; Grabbe S; Goldust M
    Int J Dermatol; 2022 Dec; 61(12):1458-1466. PubMed ID: 35193164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transformed mycosis fungoides: clinicopathological features and outcome.
    Barberio E; Thomas L; Skowron F; Balme B; Dalle S
    Br J Dermatol; 2007 Aug; 157(2):284-9. PubMed ID: 17573879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Juvenile mycosis fungoides: cutaneous T-cell lymphoma with frequent follicular involvement.
    Hodak E; Amitay-Laish I; Feinmesser M; Davidovici B; David M; Zvulunov A; Pavlotsky F; Yaniv I; Avrahami G; Ben-Amitai D
    J Am Acad Dermatol; 2014 Jun; 70(6):993-1001. PubMed ID: 24629999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining early mycosis fungoides: validation of a diagnostic algorithm proposed by the International Society for Cutaneous Lymphomas.
    Vandergriff T; Nezafati KA; Susa J; Karai L; Sanguinetti A; Hynan LS; Ambruzs JM; Oliver DH; Pandya AG
    J Cutan Pathol; 2015 May; 42(5):318-28. PubMed ID: 25721994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.